EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum MPO-DNA for Predicting the Risk of Venous Thromboembolism and the Effect of Statins in Patients with Spontaneous Intracerebral Hemorrhage

Serum-MPO-DNA zur Vorhersage des Risikos für venöse Thromboembolie und Wirkung von Statinen bei Patient:innen mit spontaner intrazerebraler Blutung

Xinyan Yan, Wenyan Huang, Yunrong Chen iD

Thrombosis and Haemostasis · 01.02.2026 · 126 (02) · 205-212

DOI: 10.1055/a-2595-1927 ↗

Auf einen Blick

In einer prospektiven Kohortenstudie war Serum-MPO-DNA bei Patient:innen mit VTE höher als bei Patient:innen ohne VTE. Statin-Anwender:innen hatten niedrigere MPO-DNA-Werte, die VTE-Inzidenz unterschied sich nicht signifikant.

Fragestellung

Welche Vorhersagekraft hat Serum-MPO-DNA für VTE bei spontaner ICH, und beeinflussen Statine MPO-DNA sowie die VTE-Inzidenz?

Methode

Prospektive Kohortenstudie mit 117 ICH-Patient:innen und 15 gesunden Kontrollen; MPO-DNA per ELISA; Zusammenhang mit VTE, ROC-Analyse und Auswertung von Statineffekten.

Ergebnisse

Median MPO-DNA bei VTE 0,304 (95 %-KI 0,231–0,349) vs. 0,188 (95 %-KI 0,159–0,236) ohne VTE. Erhöhtes MPO-DNA: OR 7,13 (95 %-KI 2,58–19,75). AUC 0,824 (95 %-KI 0,719–0,928).

Schlussfolgerung der Autor:innen

Serum-MPO-DNA ist laut den Autor:innen ein sensitiver Biomarker zur Vorhersage von VTE bei ICH. Statine könnten NETose abschwächen; größere Studien seien erforderlich.

Kernaussagen

  • MPO-DNA war bei VTE höher als ohne VTE
  • Erhöhtes MPO-DNA: OR 7,13 (95 %-KI 2,58–19,75)
  • Statine senkten MPO-DNA, VTE-Inzidenz ohne signifikanten Unterschied

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.02.2026. Verfasst von Xinyan Yan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Hunan Provincial People's Hospital and The First-Affiliated Hospital of Hunan Normal University, Changsha, Hunan, People's R…. Hauptthemen laut MEDLINE: Venous Thromboembolism, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Peroxidase, Cerebral Hemorrhage. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The General Program of the Hunan Provincial Natural Science Foundation of China, The Scientific Research Plan Project of the Health Commission of Hunan Province.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with spontaneous intracerebral hemorrhage (ICH) are at high risk of venous thromboembolism (VTE). Recent studies have shown the involvement of neutrophil extracellular traps (NETs) in thrombogenesis. To explore the predictive value of serum MPO-DNA (a NETs surrogate) for VTE and the effect of statins on serum MPO-DNA levels and the VTE incidence in ICH patients. This prospective cohort study enrolled 117 ICH patients and 15 healthy controls. Serum MPO-DNA levels were measured via ELISA. The relationship between serum MPO-DNA levels and VTE risk was analyzed. The predictive value of MPO-DNA was evaluated by ROC curves. Effects of statin on NETs and VTE incidence were evaluated. The median MPO-DNA level in patients with VTE was 0.304 (95% CI: 0.231–0.349), significantly higher than the 0.188 (95% CI: 0.159–0.236) in non-VTE patients. Elevated MPO-DNA levels were associated with an increased VTE risk (OR 7.13, 95% CI 2.58–19.75; P < 0.001), and this association persisted after adjustment. The AUC values for MPO-DNA, CRP, and D-dimer were 0.824 (95% CI: 0.719–0.928), 0.618 (95% CI: 0.481–0.754), and 0.786 (95% CI: 0.683–0.888), respectively. Moreover, statin users exhibited reduced MPO-DNA levels (0.174 vs. 0.218; P = 0.007), though VTE incidence differences (13.8% vs. 19.3%) lacked statistical significance. Serum MPO-DNA serves as a sensitive biomarker for VTE prediction in ICH, highlighting NETs as potential therapeutic targets. Statins could attenuate NETosis, but larger trials are required to validate their clinical efficacy and safety in VTE prevention for ICH patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Venous ThromboembolismHydroxymethylglutaryl-CoA Reductase InhibitorsPeroxidaseCerebral HemorrhageDNAHumansMaleFemaleMiddle AgedAgedProspective StudiesRisk FactorsBiomarkersExtracellular TrapsIncidencePredictive Value of TestsROC CurveRisk AssessmentCase-Control Studies

Substanzen

Hydroxymethylglutaryl-CoA Reductase InhibitorsPeroxidaseBiomarkersMPO protein, humanDNA

Autor:innen und Institutionen

  • Department of Neurology, Hunan Provincial People's Hospital and The First-Affiliated Hospital of Hunan Normal University, Changsha, Hunan, People's Republic of China.
  • Department of Pulmonary and Critical Care Medicine, Hunan Provincial People's Hospital and The First-Affiliated Hospital of Hunan Normal University, Changsha, Hunan, People's Republic of China.

ORCID-Profile: Yunrong Chen

Förderung

  • The General Program of the Hunan Provincial Natural Science Foundation of China
  • The Scientific Research Plan Project of the Health Commission of Hunan Province

Zitieren

APA

Yan, X., Huang, W., & Chen, Y. (2026). Serum MPO-DNA for Predicting the Risk of Venous Thromboembolism and the Effect of Statins in Patients with Spontaneous Intracerebral Hemorrhage. Thrombosis and Haemostasis, 126(02), 205-212. https://doi.org/10.1055/a-2595-1927

Vancouver

Yan X, Huang W, Chen Y. Serum MPO-DNA for Predicting the Risk of Venous Thromboembolism and the Effect of Statins in Patients with Spontaneous Intracerebral Hemorrhage. Thrombosis and Haemostasis. 2026;126(02):205-212. doi:10.1055/a-2595-1927

BibTeX
@article{Yan2026,
  author = {Yan, Xinyan and Huang, Wenyan and Chen, Yunrong},
  title = {Serum MPO-DNA for Predicting the Risk of Venous Thromboembolism and the Effect of Statins in Patients with Spontaneous Intracerebral Hemorrhage},
  journal = {Thrombosis and Haemostasis},
  year = {2026},
  volume = {126},
  number = {02},
  pages = {205--212},
  doi = {10.1055/a-2595-1927}
}
Kostenlos starten →